Hickerson Comments on U.S. Trade Relations with China
April 11, 2019
World Intellectual Property Review
Partner David Hickerson was quoted in a World Intellectual Property Review article, “Trade relations: Sending in the big guns,” about whether the Trump administration is overreaching the scope of its trade tools in its fight against Chinese bad actors.
Hickerson said he believes the administration is using the March 2018 U.S. Trade Representative’s section 301 report into “China’s Acts and Policies on IP, Technology Transfer and Innovation,” to exert influence in trade negotiations. “If Trump imposes tariffs on all Chinese imports, as has been threatened, this will be an overreach of section 301,” he said.
Hickerson also said the International Trade Commission has used section 337 cases over the past two decades to target Chinese companies. “The number of cases filed against Chinese respondents exceeds the number of ITC filings against respondents from all other countries (excluding the U.S.) combined,” he added.
Hickerson said he believes the administration is using the March 2018 U.S. Trade Representative’s section 301 report into “China’s Acts and Policies on IP, Technology Transfer and Innovation,” to exert influence in trade negotiations. “If Trump imposes tariffs on all Chinese imports, as has been threatened, this will be an overreach of section 301,” he said.
Hickerson also said the International Trade Commission has used section 337 cases over the past two decades to target Chinese companies. “The number of cases filed against Chinese respondents exceeds the number of ITC filings against respondents from all other countries (excluding the U.S.) combined,” he added.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."